drugset / Trial / NCT01490762
Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler
RandomizedCrossoverOpen-labelBasic science
Summary
This is an open-Label, Randomized Study in Healthy Normal Volunteers looking at exposure and effects (PK/PD) of multiple doses of Technosphere® Insulin (TI) using the Gen2C inhaler.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-05
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | 10 iu | Inhaled |
| Comparator | Insulin | Protein / enzyme biologic | 15 iu | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |
| Comparator | Insulin | Protein / enzyme biologic | 60 iu | Inhaled |
| Comparator | Insulin | Protein / enzyme biologic | 80 iu | Inhaled |
Indications
No indication recorded.